Search

everythinglearnresearchcommunity

for

Search:↓

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Using blood-based implants improves skin healing and reduces scarring.

FGF18 is present in beagle dog hair follicles, mainly in the inner root sheath.

Facial care products are not linked to causing frontal fibrosing alopecia.

Some overweight or obese men with long-term frontal fibrosing alopecia may have abnormal sex hormone levels.

The study concludes that early diagnosis of Frontal Fibrosing Alopecia is important, as it is often found in postmenopausal women, may be related to Lichen Planopilaris, and eyebrow hair loss is a common sign.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

The new FUE device improves hair transplant safety and efficiency.

A young woman with late-stage Vogt-Koyanagi-Harada disease was successfully treated at a hospital.

Valproic acid microemulsions improve skin delivery compared to regular solutions.

AFM can diagnose hair disorders by revealing detailed hair surface changes.

Mast cells and VEGF contribute to post-surgery adhesions, and blocking VEGF can reduce these adhesions; also, certain factors affect wound healing and fetal skin heals differently with age.

Adding stromal vascular fraction to platelet-rich plasma injections did not significantly improve hair growth in androgenetic alopecia treatment.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Hair transplants can trigger a rare scarring hair loss that is hard to treat.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Hair transplants are usually safe but can rarely cause scalp AVF, which can be effectively treated with surgery or endovascular methods.

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.

Mesotherapy with dutasteride improves hair growth and reduces symptoms in frontal fibrosing alopecia.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Androgen increases VEGF expression but not VEGFR-2 in rat corpus cavernous.

The study suggests a link between varicella-zoster virus and segmental vitiligo, with evidence of the virus disrupting skin pigment cells.

A mutation in the VDR gene affects hair cycling without needing ligand binding.

FFA has higher long-term remission rates than LPP.

Fetuin A may increase collagen production and promote scarring.

FGF20 is essential for hair follicle stem cell growth and development in fine-wool sheep.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatments.